Life Extension Final Clerance Sale

Nail Health

References

Arroyo JF, Cohen ML. Improvement of yellow nail syndrome with oral zinc supplementation.Clin Exp Dermatol. 1993 Jan;18(1):62–4.

Avner S, Nir N et al. Combination of oral terbinafine and topical ciclopirox compared to oral terbinafine for the treatment of onychomycosis. J Dermatolog Treat. 2005;16(5-6):327–39.

Ayres S, Mihan R. Yellow nail syndrome: Response to vitamin E. Arch Dermatol. 1973;108:267–8.

Barel A, Colomme M et al. Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. Arch Dermatol Res. 2005 Oct;297(4):147–53.

Cashman MW, Sloan SB (2010). "Nutrition and nail disease". Clinics in Dermatology 28 (4): 420–425.

Colombo VE, Gerber F et al. Treatment of brittle fingernails and onychoschizia with biotin: Scanning electron microscopy. J Am AcadDermatol. 1990 Dec;23(6 Pt 1):1127–32.

Dolan C, Hall JA et al. Photo quiz: Proximal white finger nails. Am Fam Physician. June 2004;69(12):2903–4.

Faergemann J, Baran R. Epidemiology, clinical presentation and diagnosis of onychomycosis. Br J Dermatol. 2003 Sep;149(Suppl 65):1–4.

Farber EM, Nall J. Nail psoriasis. Cutis. 1992 Sep;50(3):174–8.

Fawcett RS, Linford S et al. Nail abnormalities: Clues to systemic disease. Am Fam Physician. 2004 Mar 15;69(6):1417–24.

Floersheim GL. Treatment of brittle fingernails with biotin.Z Hautkr. 1989;64:41–8 [in German].

Food and Drug Administration. http://www.fda.gov/cder/drug/advisory/sporanox-lamisil/qa.htm. Accessed July 10, 2006.

Fritz K. Successful local treatment of nail psoriasis with 5-fluorourocil. Z Hautkr. 1989 Dec 15;64(12):1083–8.

Gupta AK, Jain HC et al. Prevalence and epidemiology of onychomycosis in patients visiting physicians’ offices: A multicenter Canadian survey of 15,000 patients. J Am AcadDermatol. 2000;43:244–8.

Gupta AK, Jain HC et al. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists’ offices in Ontario, Canada: A multicenter survey of 2001 patients. Int J Dermatol. 1997;36:783–7.

Gupta AK, Konnikov N et al. Prevalence and epidemiology of toenail onychomycosis in diabetic subjects: A multicentre survey. Br J Dermatol. 1998;139(4):665–71.

Hausmann M, Keller R. Yellow nail syndrome. Pneumologie. 1994 Jan;48(1):30–3.

Hay RJ. The future of onychomycosis therapy may involve a combination of approaches. Br J Dermatol. 2001;145(suppl 60):3–8.

Hiruma M, Matsushita A et al. One week pulse therapy with itraconazole(200 mg day-1) for onychomycosis: Evaluation of treatment results according to patient background. Mycoses. 2001 May;44(3-4):87–93.

Hochman LG, Scher RK et al. Brittle nails: response to daily biotin supplementation. Cutis. 1993 Apr;51(4):303-5.

Iida N, Ohsumi N. Treatment of severe deformities of the toenails by the modified Zadik method with artificial skin. Scand J PlastReconstrSurg Hand Surg. 2004;38(3):155–9.

Kawada A, Aragane Y et al. Clinical and pharmacokinetic studies of continuous itraconazole for the treatment of onychomycosis. J Dermatol. 2004 Feb;31(2):104–8.

Kyle AA, Dahl MV. Topical therapy for fungal infections. Am J Clin Dermatol. 2004;5(6):443–51.

Rigopoulos D, Katoulis AC et al. A randomized trial of amorolfine 5% solution nail lacquer in association with itraconazole pulse therapy compared with itraconazole alone in the treatment of Candida fingernail onychomycosis. Br J Dermatol. 2003 Jul;149(1):151–6.

Rommel A, Havet M et al. Syndrome des onglesjaunes: Réponse à la vitamine E. Ann Dermatol Venereol. 1985;112:625–7.

Shaw J, Body R. Best evidence topic report: Incision and drainage preferable to oral antibiotics in acute paronychial nail infection? Emerg Med J. 2005 Nov;22(11):813–4.

Sigurgeirsson B, Olafsson JH et al. Long-term effectiveness of treatment with terbinafinevsitraconazole in onychomycosis: A 5-year blinded prospective follow-up study. Arch Dermatol. 2002;138:353–7.

Sikder AU, Mamun SA et al. Study of oral itraconazole and terbinafine pulse therapy in onychomycosis. Mymensingh Med J. 2006 Jan;15(1):71–80.

Tavakkol A, Fellman S et al. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: Analysis of the elderly subgroup in Improving Results in Onychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial. Am J GeriatrPharmacother. 2006 Mar;4(1):1–13.

Tosti A, Piraccini BM et al. Relapses of onychomycosis after successful treatment with systemic antifungals: A three-year follow-up. Dermatology. 1998;197:162–6.

Venencie PY, Dicken CH. Yellow nail syndrome: Report of five cases. J Am Acad Dermatol. 1984;10:187–92.

Williams HC, Buffham R et al. Successful use of topical vitamin E solution in the treatment of nail changes in yellow nail syndrome. Arch Dermatol. July 1991;127:1023–8.

Zakeri M, Valikhani M et al. Topical calcipotriol therapy in nail psoriasis: A study of 24 cases. Dermatol Online J. 2005 Dec 1;11(3):5.